Ocular myasthenia gravis: a review

Area of Science:

• Neurology
• Ophthalmology

Background:

• Myasthenia gravis (MG) is a neuromuscular junction disorder characterized by fluctuating muscle weakness and fatigability.
• Often termed the "great masquerader," MG presents with diverse clinical manifestations.
• Ocular involvement is common in systemic myasthenia gravis, frequently appearing at diagnosis or later.

Purpose of the Study:

• To review current diagnostic methods for ocular myasthenia gravis.
• To outline current investigations pertinent to ocular myasthenia gravis.
• To summarize current treatment strategies for ocular myasthenia gravis.

Main Methods:

• Literature review of current diagnostic and treatment approaches for ocular myasthenia gravis.

Main Results:

• Ocular myasthenia gravis presents with varied symptoms and requires a multidisciplinary approach.
• Diagnosis involves a combination of clinical assessment, specific antibody testing, and electrophysiological studies.
• Treatment strategies are tailored to individual patient needs, often involving both medical and surgical interventions.

Conclusions:

• Ocular myasthenia gravis necessitates collaborative care between neurologists and ophthalmologists.
• Early and accurate diagnosis is crucial for effective management.
• Current treatment aims to improve muscle strength and quality of life for patients.